News

A Phase IV trial has demonstrated that dupilumab significantly reduces airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma.

Explore the rates of screening for breast and colorectal cancer post-pandemic.

Gut microbiome study identifies microbial ratio linked to multiple sclerosis severity, offering potential for diagnostics and therapies.

A study of 783 patients in 38 T cell therapy trials reveals reassuring results about the long-term safety of gene therapies for HIV-1 and cancer, with only 2.3% developing secondary malignancies.

Inadequate sleep duration and persistent late sleep onset are associated with significant fluctuations in blood glucose levels according to a recent study.

Given that 60% of asthma-related costs are attributed to severe, uncontrolled cases, the need for cost-effective treatment alternatives is crucial.

Time-restricted feeding (TRF), limits food intake to a set daily window, such as the 16:8 model.

World-first AI for skin cancer detection approved in Europe, cutting wait times and outperforming dermatologists with 99.8% accuracy.